Lifetime prevalence, risk, and treatment of mood and anxiety disorders in Qatar's national mental health study.

OBJECTIVES: To estimate lifetime prevalence, risk, and treatment for mental disorders and their correlates in Qatar's general population for the first time. METHODS: We conducted a national phone survey of 5,195 Qatari and Arab residents in Qatar (2019-2022) using the Composite International Diagnostic Interview Version 3.3 and estimated lifetime mood and anxiety defined diagnoses. Survival-based discrete time models, lifetime morbid risk, and treatment projections were estimated. RESULTS: Lifetime prevalence of any disorder was 28.0% and was associated with younger cohorts, females, and migrants, but lower formal education. Treatment contact in the year of disorder onset were 13.5%. The median delay in receiving treatment was 5 years (IQR = 2-13). Lifetime treatment among those with a lifetime disorder were 59.9% for non-healthcare and 63.5% for healthcare; it was 68.1% for any anxiety and 80.1% for any mood disorder after 50 years of onset. Younger cohorts and later age of onset were significantly predictors of treatment. CONCLUSIONS: Lifetime prevalence of mental disorders in Qatar is comparable to other countries. Treatment is significantly delayed and delivered largely in non-healthcare sectors thus the need for increased literacy of mental illness to reduce stigma and improve earlier help-seeking in healthcare settings.

Patterns, mechanism of injury and outcome of pediatric trauma at a level 1 trauma centre: a descriptive retrospective analysis.

Background: There is a gap in knowledge on the epidemiology of pediatric trauma in the developing countries. We aimed to describe the injury pattern, mechanism of injury (MOI), and outcomes of pediatric trauma in a level 1 trauma centre in one of the Arab Middle Eastern countries. Methods: A retrospective analysis of pediatric injury data was conducted. All trauma patients (<18 years old) requiring hospitalization between 2012 and 2021 were included. Patients were categorized and compared based on the MOI, age-group and injury severity. Results: A 3,058 pediatric patients (20% of the total trauma admissions) were included in the study. The incidence rate in 2020 was 86 cases per 100,000 pediatric population in Qatar. The majority were male (78%) and the mean age was 9.3 ± 5.7 years. Nearly 40% had head injuries. The in-hospital mortality rate was 3.8%. The median injury severity score (ISS) (interquartile range; IQR) was 9 (4-14) and Glasgow coma scale (GCS) was 15 (IQR 15-15). Almost 18% required Intensive Care admission. Road Traffic Injuries (RTI) were more frequent in 15-18 years old whereas ≤4 years group was mostly injured by falling objects. The case fatality rate was higher among females (5.0%), and in 15-18 years (4.6%) and <4 years (4.4%) group. Pedestrian injuries were more lethal among the MOI. One fifth had severe injury with a mean age of 11 ± 6 and 9.5% had ISS of ≥25. Predictors of severe injury were age (10 years old and above) and RTI. Conclusion: Almost one-fifth of the trauma admissions at the level 1 trauma centre in Qatar is due to traumatic injuries among the pediatric population. Developing strategies that are based on understanding the age- and mechanism-specific patterns of traumatic injuries among the pediatric population remains crucial.

Tobacco cessation programs and factors associated with their effectiveness in the Middle East: A systematic review.

INTRODUCTION: In Middle East countries, the average prevalence of tobacco use is relatively high. This systematic review aimed to explore different tobacco cessation programs provided in the Middle East, identify healthcare professionals providing these programs, and the factors associated with their effectiveness. METHODS: A systematic review was conducted using an electronic search of PubMed, EMBASE, Cochrane Library, ProQuest, and Web of Science, bibliographic databases between 24 January 2021 and 7 March 2021, to identify all relevant studies. The keywords used were 'tobacco cessation' and 'Middle East'. The review was undertaken applying the Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines (PRISMA). Based on the study types, several quality assessment tools including the Cochrane risk of bias tool for randomized controlled trials, MINORS for quasi-experimental studies, NIH for cross-sectional studies, NIH for pre-post studies, and CASP for cohort studies, were used. RESULTS: Among the 512 studies screened, only 30 were included in this review. Our systematic review identified different cessation methods, with some employing both behavioral change and pharmacological methods, and some utilizing only one method. Physicians are believed to be the most common providers of cessation programs, with only a few other healthcare professionals doing so. The results of this review revealed that several factors are associated with the effectiveness of tobacco cessation programs in the Middle East including individual, interpersonal, community, organizational, policy, and environmental. CONCLUSIONS: Future research should focus on examining the sociocultural and economic factors that might influence tobacco cessation programs. The included studies were of average to poor quality, highlighting the need to conduct highquality studies. The findings provide evidence to encourage the development of multilevel programs to improve the efficacy of tobacco cessation initiatives in the Middle East.